An OS to Evaluate Effectiveness and Safety of Fixed-dose Combinations of FMS/AML or FMS/AML/HCTZ
Recruiting now
Conditions studied: Hypertension,Essential
In brief
The main purpose of this observation study is to collect data on the effects and side effects for 12 weeks of the medication administration of the single-pill combinations, which are fimasartan/amlodipine or fimasartan/amlodipine/hydrochlorothiazide, based on fimasartan. (Stage 1). Also, this study will evaluate major cardiovascular events, long-term blood pressure control, and the safety by follow-up of those who consent to the extended study for about 2 years (96 weeks).(Stage 2)
Key facts
- Study ID
- NCT05413057
- Run by
- Boryung Pharmaceutical Co., Ltd
- People needed
- 20000
- Starts
- 2022-06-23
- Expected to finish
- 2026-06-01
- Last updated by the study team
- 2025-09-12
Who can join
Age: 19 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Seoul National University Bundang Hospital — Seoul, South Korea (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.